Next Science Ltd
ASX:NXS

Watchlist Manager
Next Science Ltd Logo
Next Science Ltd
ASX:NXS
Watchlist
Price: 0.135 AUD -5.26% Market Closed
Market Cap: 39.4m AUD
Have any thoughts about
Next Science Ltd?
Write Note

Next Science Ltd
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Next Science Ltd
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Next Science Ltd
ASX:NXS
Total Current Assets
$14m
CAGR 3-Years
-12%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Nanosonics Ltd
ASX:NAN
Total Current Assets
AU$198.4m
CAGR 3-Years
12%
CAGR 5-Years
13%
CAGR 10-Years
20%
Polynovo Ltd
ASX:PNV
Total Current Assets
AU$79.3m
CAGR 3-Years
70%
CAGR 5-Years
32%
CAGR 10-Years
30%
SDI Ltd
ASX:SDI
Total Current Assets
AU$64.7m
CAGR 3-Years
7%
CAGR 5-Years
9%
CAGR 10-Years
7%
Anteris Technologies Ltd
ASX:AVR
Total Current Assets
AU$35.9m
CAGR 3-Years
64%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Ansell Ltd
ASX:ANN
Total Current Assets
$1.6B
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
6%
No Stocks Found

Next Science Ltd
Glance View

Market Cap
39.4m AUD
Industry
Health Care

Next Science Ltd. engages in the research, development, and distribution of technologies with bacterial issue application. The company is headquartered in Chatswood, New South Wales. The company went IPO on 2019-04-18. The firm's principal activities include development and commercialization of XBIO technology. The XBIO technology is a non-toxic technology used in solving the problems of bacterial biofilms. The firm's product includes XPERIENCE, SURGX, BACTISURE and BLASTX. The XPERIENCE product is an antimicrobial solution used to prevent surgical site infections by rinsing away debris and microorganisms. SURGX Sterile Antimicrobial Gel is used to reduce surgical site and post-surgical infections by destroying planktonic and biofilm-based bacteria within the gel. The BLASTX is an antimicrobial wound gel.

NXS Intrinsic Value
1.454 AUD
Undervaluation 91%
Intrinsic Value
Price

See Also

What is Next Science Ltd's Total Current Assets?
Total Current Assets
14m USD

Based on the financial report for Dec 31, 2023, Next Science Ltd's Total Current Assets amounts to 14m USD.

What is Next Science Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
10%

Over the last year, the Total Current Assets growth was 69%. The average annual Total Current Assets growth rates for Next Science Ltd have been -12% over the past three years , 10% over the past five years .

Back to Top